C
Dynavax Technologies Corporation
DVAX
$11.25
$0.282.55%
C
Hold
2/21/2025Upgraded
Dynavax Technologies Corporation (DVAX) was upgraded to C from C- on 2/21/2025 due to a substantial increase in the growth index, total return index and valuation index. Operating cash flow increased 172.31% from $19.47M to $53.01M.
Dynavax Technologies Corporation (DVAX) was upgraded to C from C- on 2/21/2025 due to a substantial increase in the growth index, total return index and valuation index. Operating cash flow increased 172.31% from $19.47M to $53.01M.
C
Hold
12/2/2024Upgraded
Dynavax Technologies Corporation (DVAX) was upgraded to C- from D+ on 12/2/2024 due to an increase in the valuation index, volatility index and efficiency index. Net income increased 54.52% from $11.39M to $17.59M, and total capital increased 4.22% from $898.13M to $936.02M.
Dynavax Technologies Corporation (DVAX) was upgraded to C- from D+ on 12/2/2024 due to an increase in the valuation index, volatility index and efficiency index. Net income increased 54.52% from $11.39M to $17.59M, and total capital increased 4.22% from $898.13M to $936.02M.
D
Sell
4/11/2024Downgrade
Dynavax Technologies Corporation (DVAX) was downgraded to D+ from C- on 4/11/2024 due to a decline in the volatility index and total return index.
Dynavax Technologies Corporation (DVAX) was downgraded to D+ from C- on 4/11/2024 due to a decline in the volatility index and total return index.
C
Hold
3/11/2024Upgraded
Dynavax Technologies Corporation (DVAX) was upgraded to C- from D+ on 3/11/2024 due to an increase in the total return index and volatility index.
Dynavax Technologies Corporation (DVAX) was upgraded to C- from D+ on 3/11/2024 due to an increase in the total return index and volatility index.
D
Sell
2/23/2024Downgrade
Dynavax Technologies Corporation (DVAX) was downgraded to D+ from C on 2/23/2024 due to a significant decline in the growth index, valuation index and total return index. EBIT declined 206.37% from $6.11M to -$6.5M, earnings per share declined from $0.1009 to -$0.0001, and operating cash flow declined 55.78% from $31.13M to $13.77M.
Dynavax Technologies Corporation (DVAX) was downgraded to D+ from C on 2/23/2024 due to a significant decline in the growth index, valuation index and total return index. EBIT declined 206.37% from $6.11M to -$6.5M, earnings per share declined from $0.1009 to -$0.0001, and operating cash flow declined 55.78% from $31.13M to $13.77M.
C
Hold
12/5/2023Downgrade
Dynavax Technologies Corporation (DVAX) was downgraded to C from C+ on 12/5/2023 due to a major decline in the valuation index, total return index and efficiency index.
Dynavax Technologies Corporation (DVAX) was downgraded to C from C+ on 12/5/2023 due to a major decline in the valuation index, total return index and efficiency index.
C
Hold
10/13/2023Upgraded
Dynavax Technologies Corporation (DVAX) was upgraded to C+ from C on 10/13/2023 due to a large increase in the total return index, growth index and efficiency index. Net income increased 114.1% from -$24.33M to $3.43M, earnings per share increased from -$0.1902 to $0.0267, and EBIT increased 95.07% from -$28.65M to -$1.41M.
Dynavax Technologies Corporation (DVAX) was upgraded to C+ from C on 10/13/2023 due to a large increase in the total return index, growth index and efficiency index. Net income increased 114.1% from -$24.33M to $3.43M, earnings per share increased from -$0.1902 to $0.0267, and EBIT increased 95.07% from -$28.65M to -$1.41M.
C
Hold
5/1/2023Downgrade
Dynavax Technologies Corporation (DVAX) was downgraded to C from C+ on 5/1/2023 due to a decline in the total return index, valuation index and volatility index.
Dynavax Technologies Corporation (DVAX) was downgraded to C from C+ on 5/1/2023 due to a decline in the total return index, valuation index and volatility index.
C
Hold
4/3/2023Upgraded
Dynavax Technologies Corporation (DVAX) was upgraded to C+ from C on 4/3/2023 due to an increase in the total return index.
Dynavax Technologies Corporation (DVAX) was upgraded to C+ from C on 4/3/2023 due to an increase in the total return index.
C
Hold
3/17/2023Downgrade
Dynavax Technologies Corporation (DVAX) was downgraded to C from C+ on 3/17/2023 due to a decline in the total return index.
Dynavax Technologies Corporation (DVAX) was downgraded to C from C+ on 3/17/2023 due to a decline in the total return index.
C
Hold
2/24/2023Upgraded
Dynavax Technologies Corporation (DVAX) was upgraded to C+ from C on 2/24/2023 due to a major increase in the efficiency index, valuation index and solvency index. The quick ratio increased from 3.23 to 5.62, debt to equity declined from 0.45 to 0.39, and total capital increased 10.63% from $758.39M to $839.02M.
Dynavax Technologies Corporation (DVAX) was upgraded to C+ from C on 2/24/2023 due to a major increase in the efficiency index, valuation index and solvency index. The quick ratio increased from 3.23 to 5.62, debt to equity declined from 0.45 to 0.39, and total capital increased 10.63% from $758.39M to $839.02M.
C
Hold
9/1/2022Downgrade
Dynavax Technologies Corporation (DVAX) was downgraded to C from C+ on 9/1/2022 due to a large decline in the total return index.
Dynavax Technologies Corporation (DVAX) was downgraded to C from C+ on 9/1/2022 due to a large decline in the total return index.
C
Hold
8/8/2022Upgraded
Dynavax Technologies Corporation (DVAX) was upgraded to C+ from C on 8/8/2022 due to a significant increase in the total return index, valuation index and growth index. Earnings per share increased from $0.2163 to $0.8673, EBIT increased 299.27% from $32.37M to $129.25M, and operating cash flow increased 133.01% from -$50.44M to $16.65M.
Dynavax Technologies Corporation (DVAX) was upgraded to C+ from C on 8/8/2022 due to a significant increase in the total return index, valuation index and growth index. Earnings per share increased from $0.2163 to $0.8673, EBIT increased 299.27% from $32.37M to $129.25M, and operating cash flow increased 133.01% from -$50.44M to $16.65M.
C
Hold
7/21/2022Upgraded
Dynavax Technologies Corporation (DVAX) was upgraded to C from C- on 7/21/2022 due to an increase in the total return index and volatility index.
Dynavax Technologies Corporation (DVAX) was upgraded to C from C- on 7/21/2022 due to an increase in the total return index and volatility index.
C
Hold
5/6/2022Downgrade
Dynavax Technologies Corporation (DVAX) was downgraded to C- from C on 5/6/2022 due to a major decline in the growth index, solvency index and volatility index. Operating cash flow declined 141.86% from $120.5M to -$50.44M, earnings per share declined from $0.6585 to $0.2163, and EBIT declined 62.06% from $85.33M to $32.37M.
Dynavax Technologies Corporation (DVAX) was downgraded to C- from C on 5/6/2022 due to a major decline in the growth index, solvency index and volatility index. Operating cash flow declined 141.86% from $120.5M to -$50.44M, earnings per share declined from $0.6585 to $0.2163, and EBIT declined 62.06% from $85.33M to $32.37M.
C
Hold
3/2/2022Upgraded
Dynavax Technologies Corporation (DVAX) was upgraded to C from D on 3/2/2022 due to a significant increase in the growth index, efficiency index and valuation index. Net income increased 450.96% from -$28.43M to $99.78M, EBIT increased 436.98% from $15.89M to $85.33M, and earnings per share increased from -$0.2432 to $0.5233.
Dynavax Technologies Corporation (DVAX) was upgraded to C from D on 3/2/2022 due to a significant increase in the growth index, efficiency index and valuation index. Net income increased 450.96% from -$28.43M to $99.78M, EBIT increased 436.98% from $15.89M to $85.33M, and earnings per share increased from -$0.2432 to $0.5233.
D
Sell
11/9/2021Upgraded
Dynavax Technologies Corporation (DVAX) was upgraded to D from E+ on 11/9/2021 due to an increase in the volatility index.
Dynavax Technologies Corporation (DVAX) was upgraded to D from E+ on 11/9/2021 due to an increase in the volatility index.
E
Sell
11/8/2021Downgrade
Dynavax Technologies Corporation (DVAX) was downgraded to E+ from D on 11/8/2021 due to a major decline in the growth index and valuation index. Earnings per share declined from $0.02 to -$0.2432, and operating cash flow declined 40.24% from $110.79M to $66.21M.
Dynavax Technologies Corporation (DVAX) was downgraded to E+ from D on 11/8/2021 due to a major decline in the growth index and valuation index. Earnings per share declined from $0.02 to -$0.2432, and operating cash flow declined 40.24% from $110.79M to $66.21M.
D
Sell
5/1/2020Upgraded
Dynavax Technologies Corporation (DVAX) was upgraded to D from D- on 5/1/2020 due to an increase in the growth index.
Dynavax Technologies Corporation (DVAX) was upgraded to D from D- on 5/1/2020 due to an increase in the growth index.
D
Sell
4/28/2020Upgraded
Dynavax Technologies Corporation (DVAX) was upgraded to D- from E+ on 4/28/2020 due to a major increase in the solvency index and volatility index.
Dynavax Technologies Corporation (DVAX) was upgraded to D- from E+ on 4/28/2020 due to a major increase in the solvency index and volatility index.
E
Sell
4/13/2020Downgrade
Dynavax Technologies Corporation (DVAX) was downgraded to E+ from D- on 4/13/2020 due to a decline in the solvency index, valuation index and efficiency index. Debt to equity increased from 4.61 to 21.91, the quick ratio declined from 3.97 to 3.02, and total capital declined 11.3% from $256.79M to $227.78M.
Dynavax Technologies Corporation (DVAX) was downgraded to E+ from D- on 4/13/2020 due to a decline in the solvency index, valuation index and efficiency index. Debt to equity increased from 4.61 to 21.91, the quick ratio declined from 3.97 to 3.02, and total capital declined 11.3% from $256.79M to $227.78M.
D
Sell
10/2/2019Upgraded
Dynavax Technologies Corporation (DVAX) was upgraded to D- from E+ on 10/2/2019 due to an increase in the total return index and volatility index.
Dynavax Technologies Corporation (DVAX) was upgraded to D- from E+ on 10/2/2019 due to an increase in the total return index and volatility index.
E
Sell
8/13/2019Downgrade
Dynavax Technologies Corporation (DVAX) was downgraded to E+ from D- on 8/13/2019 due to a major decline in the solvency index, valuation index and total return index. Debt to equity increased from 4.11 to 16.84, and the quick ratio declined from 4.47 to 3.32.
Dynavax Technologies Corporation (DVAX) was downgraded to E+ from D- on 8/13/2019 due to a major decline in the solvency index, valuation index and total return index. Debt to equity increased from 4.11 to 16.84, and the quick ratio declined from 4.47 to 3.32.
D
Sell
7/31/2019Upgraded
Dynavax Technologies Corporation (DVAX) was upgraded to D- from E+ on 7/31/2019 due to an increase in the valuation index and growth index. Total revenue increased 8.56% from $5.32M to $5.77M, earnings per share increased from -$0.6375 to -$0.622, and EBIT increased 0.28% from -$37.96M to -$37.85M.
Dynavax Technologies Corporation (DVAX) was upgraded to D- from E+ on 7/31/2019 due to an increase in the valuation index and growth index. Total revenue increased 8.56% from $5.32M to $5.77M, earnings per share increased from -$0.6375 to -$0.622, and EBIT increased 0.28% from -$37.96M to -$37.85M.
E
Sell
4/8/2019Downgrade
Dynavax Technologies Corporation (DVAX) was downgraded to E+ from D- on 4/8/2019 due to a significant decline in the solvency index, volatility index and total return index. Debt to equity increased from 1.03 to 1.6, and the quick ratio declined from 5.75 to 3.92.
Dynavax Technologies Corporation (DVAX) was downgraded to E+ from D- on 4/8/2019 due to a significant decline in the solvency index, volatility index and total return index. Debt to equity increased from 1.03 to 1.6, and the quick ratio declined from 5.75 to 3.92.
D
Sell
3/11/2016Downgrade
Dynavax Technologies Corporation (DVAX) was downgraded to D- from D on 3/11/2016 due to a substantial decline in the growth index, volatility index and efficiency index. Total revenue declined 42.34% from $1.19M to $685, and total capital declined 11.42% from $211.19M to $187.08M.
Dynavax Technologies Corporation (DVAX) was downgraded to D- from D on 3/11/2016 due to a substantial decline in the growth index, volatility index and efficiency index. Total revenue declined 42.34% from $1.19M to $685, and total capital declined 11.42% from $211.19M to $187.08M.
D
Sell
5/6/2014Downgrade
Dynavax Technologies Corporation (DVAX) was downgraded to D from D+ on 5/6/2014 due to a decline in the volatility index, solvency index and efficiency index. Total capital declined 6.68% from $186.29M to $173.85M, and the quick ratio declined from 11.8 to 11.23.
Dynavax Technologies Corporation (DVAX) was downgraded to D from D+ on 5/6/2014 due to a decline in the volatility index, solvency index and efficiency index. Total capital declined 6.68% from $186.29M to $173.85M, and the quick ratio declined from 11.8 to 11.23.
D
Sell
4/30/2014Upgraded
Dynavax Technologies Corporation (DVAX) was upgraded to D+ from D on 4/30/2014 due to an increase in the volatility index.
Dynavax Technologies Corporation (DVAX) was upgraded to D+ from D on 4/30/2014 due to an increase in the volatility index.
D
Sell
4/15/2014Downgrade
Dynavax Technologies Corporation (DVAX) was downgraded to D from D+ on 4/15/2014 due to a decline in the volatility index and total return index.
Dynavax Technologies Corporation (DVAX) was downgraded to D from D+ on 4/15/2014 due to a decline in the volatility index and total return index.
D
Sell
3/18/2014Upgraded
Dynavax Technologies Corporation (DVAX) was upgraded to D+ from D on 3/18/2014 due to an increase in the solvency index and valuation index. The quick ratio increased from 5.05 to 11.8.
Dynavax Technologies Corporation (DVAX) was upgraded to D+ from D on 3/18/2014 due to an increase in the solvency index and valuation index. The quick ratio increased from 5.05 to 11.8.
NASDAQ
04/11/2025 4:00PM Eastern
Quotes delayed
